Home >> UTT Main Website
Sinopharm Vaccine
Jun 16, 2021 | Views:208028  |
Print Version
The Sinopharm Vaccine
China’s Sinopharm vaccine received World Health Organization (WHO) approval for emergency use on May 7th, 2021. Sinopharm joins vaccines produced by Pfizer-BioNTech, AstraZeneca, Moderna and Johnson & Johnson on the list of WHO-approved COVID-19 vaccines.
Trinidad and Tobago approved and began using Sinopharm on May 21st, 2021 after it took delivery of the first 100,000 doses of the vaccine on May 19th, 2021 and an additional 200,000 doses on June 14th, 2021.
The Sinopharm vaccine was developed using the traditional method, by means of an inactivated virus. In an inactivated vaccine, the virus - in this case the coronavirus causing COVID-19 - is killed or modified in such a way that it is unable to replicate. It cannot cause disease and is, therefore, suitable for those with a compromised immune system.
The inactivation is usually done using heat, radiation or chemicals to destroy the pathogen’s genetic material, which stops it from replicating.
While inactivated vaccines can trigger a strong immune response, 
They usually require a person to have booster shots to ensure ongoing protection.
Who developed it?
The state-owned China National Pharmaceutical Group (Sinopharm) and the Beijing Institute of Biological Products (BIBP) jointly developed the Sinopharm vaccine under Sinopharm’s vaccine and bioscience subsidiary, China National Biotec Group (CNBG).
What’s the recommended dosage?
The Sinopharm vaccine is administered in 2 doses (0.5 ml) given in the arm. A period of 3-4 weeks between the first and second dose. If the second dose is administered less than 3 weeks after the first, the dose does not need to be repeated. If administration of the second dose is delayed beyond 4 weeks, it should be given at the earliest possible opportunity. It is recommended that all vaccinated individuals receive two doses.
Is it safe?
The WHO Strategic Advisory Group of Experts (SAGE) thoroughly assessed the data on quality, safety and efficacy of the vaccine and has recommended it can be safely used in persons aged 18 and above.
What is vaccine efficacy and effectiveness?
Vaccine efficacy and effectiveness are often confused and used interchangeably.
Efficacy measures the performance of a vaccine measured during a clinical trial, while effectiveness refers to how well the vaccine does in the real world.
WHO experts who reviewed the Sinopharm vaccine’s data say its efficacy for symptomatic and hospitalized disease was estimated to be 79%, for all age groups combined. 
Does it work against new variants of SARS-CoV-2 virus?
As new data becomes available, WHO will update recommendations accordingly. This vaccine has not yet been evaluated in the context of circulation of widespread variants of concern.
Does it prevent infection and transmission?
There is currently no substantive data available related to the impact of the Sinopharm COVID-19 vaccine on transmission of SARS-CoV-2, the virus that causes COVID-19 disease.
Who should be vaccinated first?
While COVID-19 vaccine supplies are limited, the following persons are prioritised for vaccination in Trinidad and Tobago.
Who should not take the vaccine at this time?
Additionally persons with comorbidities (e.g. Heart disease, Hypertension, Diabetes and Cancer) should consult their physician before taking the COVID-19 vaccine.
The WHO also reminds of the need to maintain and strengthen public health measures that work: masking, physical distancing, hand washing, respiratory and cough hygiene, avoiding crowds and ensuring adequate ventilation.
Sources: World Health Organization, Sinopharm Group, Ministry of Health Trinidad & Tobago.
Message courtesy the Human Resources Division
More Results
Sep 23, 2021
News Republic Day Greetings
Sep 17, 2021
News Waiver of Library Fines - September 2021
Sep 17, 2021
News 3MT An Epidemiological Study of Breast Cancer in a Caribbean...
Sep 17, 2021
News Alumni Achievement
Sep 10, 2021
News Nestle Caribbean Youth Summit- In Partnership with CARICOM
Sep 9, 2021
News Moriche in Fashion
Sep 9, 2021
News Women Wednesday: Samantha Wallace
Sep 7, 2021
News Standalone Courses - September to December 2021
Sep 3, 2021
News Invitation to Shell NXplorers Competition - Powered by NIHER...
Sep 3, 2021
News Huawei 'Seeds for the Future' program 2021
Sep 3, 2021
News AYUSH Scholarship
Sep 3, 2021
News Alexander Takes Up Scholarship Offer in the U.S.
Sep 2, 2021
News Legall Appointed National Netball Team Manager
Sep 1, 2021
News George, Julien Selected as National U17 Basketball Coaches
Aug 30, 2021
News Independence Day Greeting
Aug 30, 2021
News Student financing options beyond GATE
Aug 27, 2021
News Dickson Selected On National Senior Women Volleyball Team
Aug 27, 2021
News Moriche In Sport
Aug 27, 2021
News UTT's Postgraduate Diploma In Education
Aug 26, 2021
News Joseph Selected to Work with St. Kitts & Nevis Patriots
Load ALL Results
Report a Broken Link/Error or make a Suggestion
ABOUT UTT

History
Accreditation
Board of Governors
Key Academic and
Corporate Staff
Job Vacancies
PROGRAMME INFO

Programme Listing
Academic Calendar
Fees
International Students
Post Graduate Studies & Research
Short Courses
STCW 10
SUBSCRIBE TO OUR
MAILING LIST

Email Address *

LATEST UPDATES

Photos
Videos
Events
Announcements
Newsletters
Privacy Statement | Disclaimer
The University of Trinidad and Tobago | (868) 642 8888 or (868) 223 4888 |e: utt.marketing@utt.edu.tt
School vector created by pch.vector - www.freepik.com
Count: 522616
Main WebsiteHOMEABOUTSTUDY AT UTT RESEARCH / LIBRARIESAPPLYCAMPUSLIFEMEDIASTAFF+ALUMNICertificate Replacement FormTranscript RequestCONTACT